UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000557
Receipt number R000000670
Scientific Title Evaluation of effect of sivelestat administration on postoperative course of patients with thoracic esophageal cancer who underwent trans-thoracic esophagectomy.
Date of disclosure of the study information 2007/01/01
Last modified on 2007/12/26 16:06:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of effect of sivelestat administration on postoperative course of patients with thoracic esophageal cancer who underwent trans-thoracic esophagectomy.

Acronym

Sivelestat on esophageal cancer

Scientific Title

Evaluation of effect of sivelestat administration on postoperative course of patients with thoracic esophageal cancer who underwent trans-thoracic esophagectomy.

Scientific Title:Acronym

Sivelestat on esophageal cancer

Region

Japan


Condition

Condition

Esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate effects of sivelestat administration on postoperative course of patients with thoracic esophageal cancer who underwent trans-thoracic esophagectomy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

*Postoperative complication
*Postoperative inflammatory parameters
*Recurrent disease

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Post operative administrations of sivelestat (day 0- day 4)

Interventions/Control_2

Control

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Thoracic esophageal cancer.
Trans-thoracic esophagectomy along with lymphadenectomy.

Key exclusion criteria

None

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takenori Ochiai

Organization

Chiba University Graduate School of Medicine

Division name

Frontier Surgery

Zip code


Address

1-8-1 Inohana Chuo-ku Chiba-city Chiba

TEL

043-226-2110

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hideaki Shimada

Organization

Chiba University Graduate School of Medicine

Division name

Frontier Surgery

Zip code


Address

1-8-1 Inohana Chuo-ku Chiba-city Chiba

TEL

043-226-2110

Homepage URL


Email



Sponsor or person

Institute

Gastrointestinal Surgery, Chiba University Hospital

Institute

Department

Personal name



Funding Source

Organization

Chiba University Graduate School of Medicine, Frontier Surgery

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2006 Year 10 Month 01 Day

Last follow-up date

2007 Year 12 Month 01 Day

Date of closure to data entry

2007 Year 12 Month 01 Day

Date trial data considered complete

2007 Year 12 Month 01 Day

Date analysis concluded

2007 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2006 Year 12 Month 25 Day

Last modified on

2007 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000670


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name